{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:49:12Z","timestamp":1786373352779,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.2215\/cjn.05870614","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T11:42:53Z","timestamp":1424950973000},"page":"776-783","source":"Crossref","is-referenced-by-count":13,"title":["Plasma Urate and Risk of a Hospital Stay with AKI"],"prefix":"10.2215","volume":"10","author":[{"given":"Keiko I.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara A.","family":"McAdams-DeMarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"K\u00f6ttgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20230601","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(13)60647-9","article-title":"Acute kidney injury: An increasing global concern.","volume":"382","author":"Lameire","year":"2013","journal-title":"Lancet"},{"key":"R2-9-20230601","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2215\/CJN.05191107","article-title":"Diagnosis, epidemiology and outcomes of acute kidney injury.","volume":"3","author":"Waikar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-9-20230601","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrneph.2012.280","article-title":"Chronic kidney disease following acute kidney injury-risk and outcomes.","volume":"9","author":"Leung","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"R5-9-20230601","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.ajkd.2013.02.349","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.","volume":"61","author":"Palevsky","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R6-9-20230601","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ajkd.2012.07.021","article-title":"Uric acid as a target of therapy in CKD.","volume":"61","author":"Jalal","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R7-9-20230601","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1093\/ndt\/gfq740","article-title":"Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: The Jerusalem Lipid Research Clinic cohort study.","volume":"26","author":"Ben-Dov","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R8-9-20230601","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000238824","article-title":"Uric acid: a novel risk factor for acute kidney injury in high-risk cardiac surgery patients?","volume":"30","author":"Ejaz","year":"2009","journal-title":"Am J Nephrol"},{"key":"R9-9-20230601","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.amjmed.2011.06.021","article-title":"Elevated uric acid increases the risk for acute kidney injury.","volume":"125","author":"Lapsia","year":"2012","journal-title":"Am J Med"},{"key":"R10-9-20230601","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5301\/jn.5000173","article-title":"Post-operative serum uric acid and acute kidney injury.","volume":"25","author":"Ejaz","year":"2012","journal-title":"J Nephrol"},{"key":"R12-9-20230601","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/aje\/kwt320","article-title":"Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population.","volume":"179","author":"Juraschek","year":"2014","journal-title":"Am J Epidemiol"},{"key":"R13-9-20230601","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R14-9-20230601","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1097\/00004872-200110000-00021","article-title":"Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.","volume":"19","author":"W\u00fcrzner","year":"2001","journal-title":"J Hypertens"},{"key":"R15-9-20230601","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3899\/jrheum.100418","article-title":"Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts.","volume":"38","author":"McAdams","year":"2011","journal-title":"J Rheumatol"},{"key":"R16-9-20230601","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/acr.20479","article-title":"Obesity and younger age at gout onset in a community-based cohort.","volume":"63","author":"DeMarco","year":"2011","journal-title":"Arthritis Care Res (Hoboken"},{"key":"R17-9-20230601","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.amjmed.2011.11.018","article-title":"Incident gout in women and association with obesity in the Atherosclerosis Risk in Communities (ARIC) Study.","volume":"125","author":"Maynard","year":"2012","journal-title":"Am J Med"},{"key":"R18-9-20230601","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/aje\/kwt299","article-title":"Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities study.","volume":"179","author":"Maynard","year":"2014","journal-title":"Am J Epidemiol"},{"key":"R19-9-20230601","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1751-7176.2012.00674.x","article-title":"Hypertension and the risk of incident gout in a population-based study: The Atherosclerosis Risk in Communities cohort.","volume":"14","author":"McAdams-DeMarco","year":"2012","journal-title":"J Clin Hypertens (Greenwich"},{"key":"R20-9-20230601","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.33315","article-title":"Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: The Atherosclerosis Risk in Communities cohort study.","volume":"64","author":"McAdams DeMarco","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R22-9-20230601","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1186\/ar4026","article-title":"Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study.","volume":"14","author":"McAdams-DeMarco","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R23-9-20230601","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology.","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"R24-9-20230601","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCGENETICS.109.934455","article-title":"Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors.","volume":"3","author":"Yang","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"R25-9-20230601","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1681\/ASN.2010010128","article-title":"Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury.","volume":"21","author":"Grams","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R26-9-20230601","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2215\/CJN.07650713","article-title":"Performance and limitations of administrative data in the identification of AKI.","volume":"9","author":"Grams","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R27-9-20230601","doi-asserted-by":"crossref","first-page":"e56864","DOI":"10.1371\/journal.pone.0056864","article-title":"High serum uric acid and increased risk of type 2 diabetes: A systemic review and meta-analysis of prospective cohort studies.","volume":"8","author":"Lv","year":"2013","journal-title":"PLoS ONE"},{"key":"R28-9-20230601","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.HYP.0000150784.92944.9a","article-title":"Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence.","volume":"45","author":"Sundstr\u00f6m","year":"2005","journal-title":"Hypertension"},{"key":"R29-9-20230601","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2008.05.022","article-title":"Uric acid: A marker of increased cardiovascular risk.","volume":"202","author":"Gagliardi","year":"2009","journal-title":"Atherosclerosis"},{"key":"R30-9-20230601","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/aje\/kwj062","article-title":"Limits to causal inference based on Mendelian randomization: A comparison with randomized controlled trials.","volume":"163","author":"Nitsch","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R31-9-20230601","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury.","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"R32-9-20230601","doi-asserted-by":"crossref","first-page":"f4262","DOI":"10.1136\/bmj.f4262","article-title":"Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts.","volume":"347","author":"Palmer","year":"2013","journal-title":"BMJ"},{"key":"R33-9-20230601","doi-asserted-by":"crossref","first-page":"e7729","DOI":"10.1371\/journal.pone.0007729","article-title":"Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease.","volume":"4","author":"Stark","year":"2009","journal-title":"PLoS ONE"},{"key":"R34-9-20230601","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/ije\/dyp397","article-title":"Bayesian methods for instrumental variable analysis with genetic instruments (\u2018Mendelian randomization\u2019): Example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome.","volume":"39","author":"McKeigue","year":"2010","journal-title":"Int J Epidemiol"},{"key":"R35-9-20230601","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"R36-9-20230601","doi-asserted-by":"crossref","first-page":"F373","DOI":"10.1152\/ajprenal.00104.2006","article-title":"Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappaB.","volume":"292","author":"Han","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R37-9-20230601","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V89.2.577","article-title":"The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice.","volume":"89","author":"Netea","year":"1997","journal-title":"Blood"},{"key":"R38-9-20230601","doi-asserted-by":"crossref","first-page":"F710","DOI":"10.1152\/ajprenal.00454.2007","article-title":"Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome.","volume":"294","author":"S\u00e1nchez-Lozada","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R39-9-20230601","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11892-013-0381-0","article-title":"Uric acid lowering to prevent kidney function loss in diabetes: The Preventing Early Renal Function Loss (PERL) allopurinol study.","volume":"13","author":"Maahs","year":"2013","journal-title":"Curr Diab Rep"},{"key":"R41-9-20230601","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/joim.12120","article-title":"Longitudinal association between serum urate and subclinical atherosclerosis: The Coronary Artery Risk Development in Young Adults (CARDIA) study.","volume":"274","author":"Wang","year":"2013","journal-title":"J Intern Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201505000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:06Z","timestamp":1786369506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201505000-00009"}},"subtitle":["The Atherosclerosis Risk in Communities Study"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.05870614","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}